Autoimmune Disease – Ayurved Healing

Ayurvedic Approach to Lupus (SLE): Managing Pitta-Vata Autoimmunity Naturally

Priya Nair — Wed, 13 May 2026 10:30:00 +0000

Herbs With Evidence…

` jumps straight to `

` with no body paragraph. Fixing.

Here is the corrected article.

The diagnosis arrived on a Tuesday in autumn – a date my friend Kavya remembers with the precision of someone who knows exactly where they were when their life changed. Systemic lupus erythematosus. The rheumatologist explained the disease, the medication protocol, and the lifestyle modifications with practiced efficiency. What he did not explain, because conventional medicine does not have language for it, is what it means to live in a body that has turned against itself. The fear that comes with every new symptom – is this the disease advancing? What triggered this flare? Am I doing everything wrong?

Kavya eventually found her way to an Ayurvedic practitioner as a complement to her rheumatology care – not to replace it, but to have a framework for understanding her condition that included her body’s patterns, her triggers, and her strengths. That framework made the experience of having lupus feel less like a battle she was losing and more like a complex relationship she could learn to navigate.

I want to share what that framework looks like, with the clarity that this is supportive care alongside rheumatology – not an alternative to it.

SLE Through an Ayurvedic Lens

Systemic lupus erythematosus does not have a precise classical Ayurvedic equivalent – it was not described as a distinct clinical entity in ancient texts, because those physicians did not have the laboratory tools to identify autoantibodies. However, the clinical presentation of SLE maps onto patterns described in classical texts, and skilled practitioners can identify the dominant dosha imbalance and tissue pathology involved. Classical authors describe Raktapitta and Pittaja-Kushta type disturbances – heat and reactivity lodged in the blood and skin – alongside Ojakshaya, the depletion of the vital essence that governs resilience.

SLE is characterized by immune complex deposition in multiple organ systems, complement activation, inflammatory damage to skin, joints, kidneys, nervous system, and serous membranes, and a flare-remission pattern that correlates with identifiable triggers. From an Ayurvedic perspective, the dominant pathological pattern involves:

Pitta vitiation in Rakta dhatu (blood tissue): Autoantibody-driven inflammation, the butterfly rash, photosensitivity, and fever all reflect excess Pitta in the blood and skin
Vata vitiation causing tissue spread: The systemic, multi-organ nature of SLE reflects Vata’s role in carrying vitiated Pitta to distant tissues through the channels (srotas)
Ojas depletion: The fatigue, immune dysregulation, and susceptibility to infections that characterize SLE reflect Ojakshaya – the decline of the vital essence that underlies immune competence and self-recognition

This is not simply a Pitta disorder, which is why generically Pitta-pacifying treatment often fails: the combination of Pitta inflammation with Vata’s dissemination requires a nuanced approach that pacifies Pitta without aggravating Vata, and rebuilds Ojas without feeding the inflammatory process.

SLE Flare Triggers Through Ayurvedic Eyes

One of the most practically valuable aspects of the Ayurvedic framework for SLE is its precise language for triggers. Pitta is aggravated by:

Sunlight and UV exposure (photosensitivity, a hallmark SLE trigger)
Hot, spicy, pungent, sour foods (tomatoes, vinegar, fermented foods, alcohol, chili)
Emotional anger, frustration, and competitive pressure
Skipped meals, irregular eating, and excessive fasting
Late nights and sleep disruption
Summer heat and humid conditions

Vata is aggravated by:

Physical and emotional stress
Cold, dry, windy conditions
Overexertion, travel, irregular routine
Dry, light, cold foods
Excessive screen exposure and mental stimulation without rest

The overlap between these lists and the documented trigger patterns for SLE flares is striking. Modern rheumatology identifies UV exposure, stress, infections, and certain medications as flare triggers. Ayurveda adds the dietary and behavioral specificity that helps women understand the daily texture of living with the disease.

Herbs Relevant to Autoimmune Modulation

The herbs below are chosen first for their classical actions – Rasayana (rejuvenation), Pitta-pacification, and support of Ojas – and, where it exists, for supporting clinical research. None is a substitute for prescribed therapy, and several carry real interaction risks in autoimmune disease. Treat this as a map for an informed conversation with both an experienced Ayurvedic practitioner and your rheumatologist, not as a self-treatment protocol.

Guduchi: The Immunomodulator

Guduchi (Tinospora cordifolia), called Amrita – “nectar of immortality” – is among the most esteemed Rasayana herbs of classical Ayurveda. Charaka, Sushruta, and the later nighantus describe it for Jwara (fever), Pittaja and Raktaja disorders, Kushta (skin disease), and Pandu, and as a restorative that strengthens the body’s defenses rather than crudely suppressing or stimulating them. This balancing quality is the reason practitioners favor it in autoimmune contexts, where the goal is intelligent modulation rather than further blunting of an already over-treated immune system.

Modern pharmacological reviews of Tinospora cordifolia describe immunomodulatory constituents (such as the polysaccharide G1-4A and several alkaloids) and validate a number of its traditional uses through experimental and early clinical work, though high-quality trials specifically in SLE are lacking. Dose: 400mg standardized extract twice daily, or 5g dried stem as decoction. Take only with your physician’s knowledge.

Caution: Guduchi should not be combined with immunosuppressant medications such as mycophenolate, azathioprine, or high-dose prednisone without rheumatology consultation, as its immunomodulatory effects may interact unpredictably with drug action. Rare cases of drug-induced liver injury have been reported with prolonged or unsupervised use, so periodic monitoring is sensible.

Turmeric (Haridra): Anti-Inflammatory Foundation

Haridra (Curcuma longa) is classically tikta-katu in taste with a Pitta- and Kapha-pacifying, Shothahara (anti-inflammatory), Varnya (complexion-improving), and Kushtaghna (skin-clearing) action – a natural fit for heat lodged in blood and skin. Its principal compound, curcumin, is one of the better-studied plant anti-inflammatories: reviews of its mechanism describe inhibition of NF-κB (a master inflammatory transcription factor) through blockade of IκB kinase, alongside effects on MAPK/ERK and JAK/STAT signaling.

A small randomized, placebo-controlled trial in 24 patients with relapsing or refractory lupus nephritis (Khajehdehi et al., Journal of Renal Nutrition, 2012) found that oral turmeric supplementation over three months significantly decreased proteinuria, hematuria, and systolic blood pressure, and was well tolerated. The study was small and used whole turmeric rather than high-dose isolated curcumin, so the result is promising but preliminary – not a basis for replacing kidney-directed medical therapy. Dose: 500mg curcumin (with 5mg piperine for absorption) twice daily, or 1/4 teaspoon turmeric simmered in warm milk and ghee daily as a dietary practice. Note: Curcumin has antiplatelet effects – discuss with your rheumatologist if you take warfarin or aspirin.

Amalaki: Systemic Antioxidant

Oxidative stress is a central pathological feature of SLE: immune complex deposition triggers reactive oxygen species that amplify tissue damage. Amalaki (Phyllanthus emblica) is the foremost Rasayana of classical Ayurveda – the chief ingredient of Chyawanprash and one of the three fruits of Triphala – and is unusual in pacifying all three doshas while being especially cooling and Pitta-soothing (amla in taste yet sheeta in potency). It is among the richest plant sources of vitamin C and is high in tannins and polyphenols that contribute antioxidant activity; some other fruits, such as Kakadu plum, camu camu, and acerola, are documented to contain even more vitamin C.

For women with SLE, Amalaki offers broad nutritive and antioxidant support consistent with its Rasayana reputation, without immunosuppressive activity. Dose: 1g standardized extract or 5g fresh powder daily, taken in the morning. As with any vitamin-C-rich supplement, mention regular use to your rheumatologist, since high intakes can interact with some lab tests and medications.

Brahmi: Neuroprotection and Stress Reduction

Neuropsychiatric SLE (NPSLE) affects a substantial minority of patients and includes cognitive dysfunction, anxiety, and low mood. Brahmi (Bacopa monnieri) is a classical Medhya Rasayana – a herb that nourishes intellect, memory, and the mind (manas) – and is traditionally used to steady an agitated, overheated mental state. A meta-analysis of randomized controlled trials (Kongkeaw et al., Journal of Ethnopharmacology, 2014) found that standardized Bacopa extract improved cognition, particularly speed of attention, with shortened Trail B times and faster choice reaction times. This evidence is for cognition in general populations rather than SLE specifically, so its application to NPSLE is by reasonable extension, not direct proof. Dose: 300mg standardized extract (around 45% bacosides) twice daily.

Ashwagandha: Adaptogenic Support With a Caution

Ashwagandha (Withania somnifera) is an Ojas-building, Vata- and Kapha-pacifying Balya and Rasayana that would seem ideal for the fatigue and depletion of SLE – except for one critical consideration. Ashwagandha is documented to stimulate aspects of immune function (increasing NK cell activity and antibody production). In autoimmune conditions, immune stimulation can in theory worsen disease activity.

Clinical practice is nuanced: some Ayurvedic practitioners use low-dose ashwagandha (150-300mg, rather than the 600mg common for non-autoimmune use) with careful monitoring for Ojas-building in stable, remission-phase patients. Others avoid it entirely. This is a decision that requires individualized assessment by a practitioner experienced with autoimmune conditions. Do not self-administer ashwagandha if you have active SLE without practitioner guidance.

Dietary Protocol for SLE

The dietary approach for lupus in Ayurveda is primarily Pitta-pacifying, with attention to Vata when systemic spread symptoms are prominent. The aim is food that is cooling, easy to digest, and nourishing without being heating, sour, or fermented.

Category	Include	Minimize or Avoid
Vegetables	Bitter gourd, zucchini, cooked leafy greens, cucumber, coconut	Nightshades (tomato, pepper, eggplant) during flares; excess raw onion and garlic
Fruits	Sweet seasonal fruits, pomegranate, dates, coconut water, amla	Citrus in excess; very sour or unripe fruits during flares
Grains	Basmati rice, moong dal, oats, barley	Wheat and gluten may worsen inflammation in some individuals (assess individually)
Fats	Ghee (1-2 tsp daily) and coconut oil – both cooling and Pitta-pacifying	Omega-6-heavy seed oils (corn, sunflower, soybean); heating oils such as mustard and sesame/tila taila, which are warming and better suited to Vata
Proteins	Moong dal, split mung, well-soaked lentils, small amounts of paneer, egg white if tolerated	Red meat; fish and seafood (classically guru/snigdha/ushna and Pitta-aggravating); excess legumes during flares if digestion is weak
Spices	Turmeric, coriander, fennel, cardamom, cumin	Excess chili, hot peppers, mustard seeds during flares

The role of omega-3 fatty acids deserves an honest note. Randomized trials in SLE have given mixed but encouraging signals: a 24-week study found that omega-3 supplementation improved a disease-activity score (SLAM-R), endothelial function, and oxidative stress (Wright et al., Annals of the Rheumatic Diseases, 2008), while a later placebo-controlled trial reported improvement in the physician’s global assessment but no clear change in fatigue or SLEDAI (Arriens et al., Nutrition Journal, 2015). Here modern evidence and classical guidance diverge: Ayurveda regards fish as guru (heavy), snigdha, and ushna (heating), and therefore Pitta-aggravating, so the classical texts do not recommend oily fish for an inflammatory Pitta condition. If omega-3s are pursued, the practical resolution is to treat them as a supplement decision made with your rheumatologist rather than as a Pitta-pacifying food.

Daily Routine for SLE Management

Routine is medicine in Ayurveda. For a Vata-Pitta condition like SLE, unpredictability and irregularity in the daily schedule are themselves Vata-aggravating. The following dinacharya elements are particularly important:

Consistent sleep and wake times: Sleep before 10pm, wake before 6am. Disrupted sleep is both a trigger and a consequence of SLE flares.
Avoid midday sun: Sun exposure is the strongest external SLE trigger. Schedule outdoor activities before 9am or after 4pm.
Daily Abhyanga with coconut oil: Coconut oil is cooling (Pitta-pacifying) and soothing. 10-15 minutes of self-massage before bathing, particularly during remission periods. Avoid vigorous massage during active flares with joint inflammation.
Cooling pranayama: Sheetali (cooling breath) and Nadi Shodhana (alternate nostril breathing) help calm an over-activated, heated state. More on technique is in our guide on pranayama for stress.
Gentle yoga, not hot or vigorous: Yin yoga, restorative yoga, and gentle Hatha are appropriate. Hot yoga and vigorous Vinyasa will aggravate Pitta and trigger fatigue.

For more on how Ayurvedic lifestyle practices support women’s health, see our guide on cycle syncing with Ayurveda.

The Conversation With Your Rheumatologist

The most important practical advice for anyone with SLE who wants to integrate Ayurvedic support is full transparency with your rheumatologist. Several herbs described in this article have potential interactions with SLE medications:

Guduchi with immunosuppressants: requires monitoring
Turmeric/curcumin with anticoagulants: antiplatelet effects
Amalaki with methotrexate: high-dose vitamin C interactions
Any immune-stimulating herb with azathioprine or mycophenolate: potential reduced drug efficacy

A rheumatologist who dismisses Ayurvedic approaches without engagement is doing their patient a disservice. A patient who implements Ayurvedic herbs secretly, without disclosure, is putting themselves at risk. The ideal is a collaborative conversation where both approaches inform each other.

Critical disclaimer: SLE is a potentially life-threatening autoimmune condition requiring specialist medical management. The Ayurvedic approaches described in this article are complementary measures to be used alongside, not instead of, prescribed rheumatological care. Never discontinue prescribed medications (hydroxychloroquine, prednisone, immunosuppressants) without your rheumatologist’s guidance. Always disclose all herbs and supplements to your medical team, and consult a qualified Ayurvedic practitioner before starting any herb. During active flares with organ involvement (lupus nephritis, serositis, CNS lupus), focus entirely on medical management; Ayurvedic support is most appropriate during remission or mild disease. This article is for educational purposes only.

Priya Nair is a women’s wellness specialist and Ayurvedic health educator who works with women managing autoimmune and inflammatory conditions through integrative wellness approaches. She emphasizes collaborative care between traditional and modern medicine.

References

Clinical Evidence for Guduchi (Giloy) in Autoimmune Conditions: 2026 Review

Dr. Meera Iyer — Sun, 05 Apr 2026 09:00:00 +0000

Guduchi (Tinospora cordifolia), widely called Giloy in Hindi, is often marketed as an “immune-balancing” herb. That phrase requires caution in rheumatoid arthritis, lupus, multiple sclerosis, inflammatory bowel disease, psoriasis, autoimmune thyroid disease, and autoimmune hepatitis. Laboratory and animal studies show that Guduchi can influence inflammatory and immune pathways, but direct evidence that it safely treats human autoimmune disease is limited. Published reports also associate Guduchi products with liver injury, sometimes with autoimmune features. A responsible review must therefore separate classical use, preclinical mechanisms, human evidence, and modern safety signals.

What Guduchi Is and Why Autoimmune Patients Seek It

The Ayurvedic Pharmacopoeia of India identifies Guduchi as the dried, mature stem of Tinospora cordifolia, while noting that the fresh drug is also used. It lists Amritavalli, Amrita, Madhuparni, Guduchika, and Chinnobhava among its Sanskrit synonyms, and Giloe or Gurcha among its Hindi names. Patients are attracted by descriptions of immunomodulatory and anti-inflammatory activity, but “immunomodulatory” is a broad experimental term; it does not mean that Guduchi has been proved to correct every overactive immune response.

The Official Ayurvedic Pharmacopoeial Profile

The official monograph records bitter and astringent taste (tikta, kashaya rasa), light quality (laghu guna), heating potency (ushna virya), and sweet post-digestive effect (madhura vipaka). Listed actions are balya, dipana, rasayana, sangrahi, tridoshashamaka, raktashodhaka, and jvaraghna. “Ojas-vardhaka” is not listed as a formal action in this monograph and should not be attributed to it.

Traditional indications include jvara, kushtha, pandu, prameha, vatarakta, and kamala. These categories should not be converted automatically into modern diagnoses. A reference to vatarakta is not clinical proof of efficacy in rheumatoid arthritis, while kamala is not evidence that every Guduchi preparation is safe in jaundice or liver disease.

Established Phytochemistry

The pharmacopoeial monograph broadly identifies terpenoids and alkaloids. Reviews additionally report diterpenoid lactones, glycosides, steroids, phenolic and aliphatic compounds, and polysaccharides. Described constituents include magnoflorine, palmatine, berberine, tinosporide-related compounds, cordifoliosides, syringin, and polysaccharide fractions. Composition can vary with the plant part, growing conditions, storage, extraction, and manufacturing process.

Alkaloids: Magnoflorine, palmatine, and berberine are reported, but activity of an isolated compound cannot be assigned automatically to every whole-herb product.
Diterpenoids and glycosides: Tinosporide-related and cordifolioside compounds occur in the literature, with amounts dependent on the preparation.
Polysaccharides: Arabinogalactan and glucan fractions have shown macrophage- or immune-related effects in experimental systems.

A 2010 review indexed as PMID 20814526 assembled Ayurvedic uses, phytochemistry, and experimental pharmacology. It supports biological plausibility, not blanket clinical validation.

Preclinical Evidence in Autoimmune-Relevant Models

The strongest positive findings are preclinical. They help identify pathways for further research, but cannot determine clinical benefit, effective human dosing, long-term safety, or interactions. Laboratory extracts may also differ substantially from juices, powders, decoctions, and tablets.

Adjuvant-Induced Arthritis

A 2015 study, PMID 26467057, tested a T. cordifolia extract in rats with adjuvant-induced arthritis. Treatment reduced arthritic inflammation and was associated with less bone and cartilage damage and changes in inflammatory mediators. This supports anti-arthritic plausibility, not human efficacy. PMCID PMC8082752 is this adjuvant-induced-arthritis paper; it should not be cited as though it were itself a collagen-induced-arthritis study.

Th17-Related Research

A 2023 in-vitro study, PMID 36699055 and PMCID PMC9868420, examined a water-soluble Guduchi extract in cultured Th17 cells using transcriptomic and computational analyses. It supports a possible effect on Th17 differentiation or proliferation under laboratory conditions. It did not demonstrate patient remission, establish an oral dose, or prove that Guduchi promotes regulatory T cells in people.

Human Clinical Evidence: What Actually Exists

Direct human evidence is much thinner than the preclinical literature. Studies in allergic rhinitis, infections, physical stress, or metabolic conditions cannot establish benefit in autoimmune disease. Reliable assessment requires a defined diagnosis, characterized product, appropriate comparator, meaningful clinical outcomes, and adequate follow-up.

The Rheumatoid-Arthritis Polyherbal Trial

A randomized, investigator-blind study, PMID 21773714, enrolled 121 patients with active rheumatoid arthritis for 24 weeks. It compared a standardized polyherbal formulation based on T. cordifolia and Zingiber officinale, a Semecarpus anacardium preparation, and hydroxychloroquine sulfate. The abstract reported ACR20 responses of 44%, 36%, and 51%, respectively, and 42 dropouts.

This trial is clinically relevant but does not isolate Guduchi because its arm used a combination formulation. It was preliminary, investigator-blind rather than a large double-blind placebo-controlled efficacy trial, and had substantial attrition. It supports further research on one standardized formulation; it does not show that commercial Giloy can replace hydroxychloroquine, methotrexate, biologics, corticosteroids, or other prescribed treatment.

Other Autoimmune Diseases

No adequate controlled human evidence was located showing that Guduchi alone treats lupus, multiple sclerosis, autoimmune thyroid disease, inflammatory bowel disease, psoriasis, or autoimmune hepatitis. Claims involving macrophages, natural-killer cells, cytokines, or T-cell subsets should be labelled experimental. Immune-marker changes in healthy or non-autoimmune populations do not establish benefit in autoimmune patients.

The Immunomodulation Paradox

“Immunomodulation” can include stimulation of some immune functions, suppression of others, or context-dependent changes. Increased phagocytosis is not equivalent to suppression of pathogenic autoantibodies, prevention of joint erosion, or control of bowel or neurological inflammation. Ayurvedic rasayana is also broader than a modern immune drug and should not be translated into a promise that Guduchi normalizes every autoimmune disorder.

The Th17 study offers a hypothesis, not proof of universal immune balancing. The most accurate conclusion is that Guduchi has measurable immune activity, while its direction, clinical relevance, and safety depend on the preparation and patient.

Research Evidence Summary

The table separates experimental findings, indirect clinical evidence, and safety observations so that promising mechanisms are not mistaken for established treatment.

Question	Evidence	Supported Conclusion	Limitation
Arthritis mechanisms	Rat adjuvant-induced arthritis	Anti-inflammatory plausibility	Not a human trial
Th17 activity	In-vitro cell study	Possible Th17 effects	No patient outcomes or proven Treg benefit
Rheumatoid arthritis	Preliminary randomized polyherbal study	Signal for further research	Guduchi effect not isolated
Lupus, MS, IBD, psoriasis	Indirect or preclinical literature	Research hypotheses	No adequate controlled evidence
Liver safety	Case series and multicentre data	Credible liver-injury signal	Incidence cannot be calculated

Ayurvedic Formulations Are Not a Universal Protocol

There is no single pharmacopoeial “Guduchi autoimmune protocol.” Ayurveda selects treatment according to the person, disease presentation, strength, digestion, stage, and therapeutic objective. Classical concepts such as ama, agni, vatarakta, and rasayana should not be used as simple substitutes for biomedical immunology.

Guduchi occurs in compound formulations, but evidence for one formulation cannot be transferred to another. Turmeric, dried ginger, Amalaki, or Pippali may also be used in Ayurveda, yet their inclusion does not make a mixture appropriate for every autoimmune patient.

Practical Dosage Considerations

The Ayurvedic Pharmacopoeia gives 3–6 g of Guduchi stem powder and 20–30 g of the drug for preparing a decoction. These are approximate adult oral ranges for the official crude drug, not personalized instructions for autoimmune disease and not equivalent to concentrated-extract doses. The monograph does not establish a universal fresh-juice dose on an empty stomach, a standard 250–500 mg tablet twice daily, or a mandatory three-month course.

Fresh stem, powder, decoction, Guduchi sattva, fermented preparations, and extracts are not interchangeable gram for gram. A clinical plan should identify the exact preparation, dose, duration, treatment goal, conventional medicines, and stopping criteria.

The Liver Safety Question

A 2021 case series, PMID 34230786, described six patients with acute hepatitis after Guduchi consumption and reported autoimmune-like features. The authors raised the possibility of immune-mediated injury or unmasking of previously silent autoimmune liver disease. Case reports cannot establish incidence, but the recurring pattern and improvement after withdrawal make the signal clinically important.

A nationwide multicentre retrospective study, PMID 35037744, reported 43 patients with suspected Giloy-associated liver injury from 13 Indian centres. Presentations included acute hepatitis, worsening chronic liver disease, and acute liver failure; autoimmune markers or histological features occurred in many cases. Causality was assessed as probable in 67.4% and possible in the remainder. These findings do not mean every user will develop hepatitis, but they contradict claims that the risk is merely hypothetical.

The Ministry of Ayush disputed a simple causal interpretation and emphasized possible confusion between T. cordifolia and similar-looking T. crispa. Substitution is a genuine quality concern, but later hepatology reports described authentication and analysis of retrieved products, so misidentification cannot explain every event. LiverTox, updated in June 2025, classifies Tinospora as a well-established cause of clinically apparent liver injury and describes a usually hepatocellular pattern, sometimes with autoantibodies or autoimmune-like biopsy findings.

Product Identity and Quality Control

The official drug is the identified mature stem of T. cordifolia. A product should state the botanical name, plant part, manufacturer, batch, and dosage form. Pharmacopoeial identity and purity testing, together with batch traceability, can help reduce substitution and contamination risk, but no single “standardized tinosporide” claim guarantees efficacy or liver safety. Prefer traceable products from licensed manufacturers and avoid anonymous mixtures or labels claiming to replace prescribed treatment.

Safety and Disclaimer

Critical safety notice: Guduchi must not replace corticosteroids, hydroxychloroquine, methotrexate, biologic medicines, JAK inhibitors, or other prescribed autoimmune treatment. Do not start, stop, or reduce conventional therapy without the treating physician. Consult both the physician managing the condition and a qualified Ayurvedic practitioner before considering Guduchi.

Interaction data are incomplete, so absence of a published interaction does not prove compatibility with immunosuppressants. Self-treatment is particularly inappropriate in autoimmune hepatitis, current or previous liver disease, or unexplained abnormal liver tests. Stop the suspected product and seek prompt medical care for yellow eyes or skin, dark urine, persistent nausea, unusual fatigue, itching, pale stools, or right-upper-abdominal pain.

Safety during pregnancy and breastfeeding is not adequately established, so routine supplementation should be avoided without individualized professional advice. Any liver-test monitoring plan should be decided by the treating clinician and must not delay evaluation of symptoms.

Clinical Bottom Line

Guduchi has an authentic Ayurvedic pharmacopoeial profile as a rasayana and tridoshashamaka drug with tikta-kashaya rasa, laghu guna, ushna virya, and madhura vipaka. Experimental arthritis and Th17 studies provide plausible mechanisms, and one preliminary trial offers indirect evidence for a standardized Guduchi-ginger formulation. They do not establish Guduchi alone as an autoimmune treatment. Given the liver-injury literature, any use should be individualized, quality-controlled, time-limited, and coordinated with qualified healthcare professionals.